Softwr

Healthcare · head to head

Amwell vs Annalise.ai

A

Amwell

Healthcare

Telehealth platform connecting patients with providers

From
$99/visit
Rated
-
Annalise.ai logo

Annalise.ai

Healthcare

Multi-finding chest X-ray and head CT triage AI with FDA clearance on named findings, not on the whole model

From
On request
Rated
-

The short version

  • Each has a real cost: Amwell listed on UK G-Cloud 14 at £6.25 per user for SilverCloud by Amwell, submitted directly by American Well Corporation UK Limited; Annalise.ai the United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.
  • They diverge on capability: Amwell covers Video Consultations, Annalise.ai covers Annalise Enterprise CXR.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Amwell and Annalise.ai actually diverge.

Attributes where Amwell and Annalise.ai differ
AttributeAmwellAnnalise.ai
Starting price$99/visitOn request
Pricing modelsubscriptionquote
PlatformsWeb, MobileWeb, Cloud, On-premise
Founded2002Unknown

Identical on both: free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Amwell

  • Video Consultations
  • Phone Consultations
  • Mental Health Services
  • Prescription Services
  • Digital Prescriptions
  • EHR Systems
  • Health Plans
  • HIPAA

Only in Annalise.ai

  • Annalise Enterprise CXR
  • Annalise Enterprise CTB
  • Triage and notification
  • Worklist reprioritisation
  • Localisation overlays
  • Confidence output
  • PACS-native deployment
  • On-premise or cloud inference

What people use each for

The jobs each tool is most often brought in to do.

Amwell

  • Patient Carenot Annalise.ai
  • Medical Recordsnot Annalise.ai
  • Practice Managementnot Annalise.ai
  • Telehealthnot Annalise.ai

Annalise.ai

  • An emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnestnot Amwell
  • A teleradiology provider covering many small hospitals that needs consistent triage before a human readsnot Amwell
  • A screening programme in Europe where the broader CE marked decision support indication, rather than the narrow United States triage clearance, is what is being deployednot Amwell
  • A radiology department building an AI governance programme that wants one vendor covering both chest radiograph and head CT rather than contracting two separate algorithm suppliersnot Amwell

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Amwell

  • Listed on UK G-Cloud 14 at £6.25 per user for SilverCloud by Amwell, submitted directly by American Well Corporation UK Limited

Annalise.ai

  • The United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.
  • Triage AI reprioritises a worklist but does not change clinical decisions on its own, so departments that do not redesign how urgent studies are picked up see no measurable improvement in time to treatment.
  • Published validation is largely reader study evidence on detection of individual findings; prospective evidence of shorter time to treatment in routine emergency care is thin.
  • The Annalise brand is being migrated under the Harrison.ai name for the critical care offering, which creates ambiguity in multi-year contracts about what product name is actually being supported.
  • A high finding count raises the alert burden, and departments report that low prevalence findings generate false positives that erode radiologist trust unless the alerting thresholds are tuned locally.

Pricing, plan by plan

Amwell

$99/visit
  • On-Demand Visit$99/visit
    • 24/7 availability
    • Board-certified doctors
    • Digital prescriptions

Annalise.ai

On request
  • Annalise Enterprise$undefined/year
    • Priced per study analysed or as an annual volume subscription
    • CXR and CTB licensed separately
    • Cleared finding set differs by market, which changes what you are buying

Which should you pick?

Choose Amwell if

  • You need video consultations.
  • You work on Web, Mobile.
  • You also want phone consultations.

Choose Annalise.ai if

  • You need annalise enterprise cxr.
  • You work on Web, Cloud, On-premise.
  • You also want annalise enterprise ctb.

Questions people ask

Is Amwell or Annalise.ai better?
Neither clearly leads. Amwell starts at $99/visit and Annalise.ai at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Amwell or Annalise.ai?
Amwell starts at $99/visit and Annalise.ai at On request.
Does Amwell or Annalise.ai run on more platforms?
Amwell runs on Web, Mobile. Annalise.ai runs on Web, Cloud, On-premise.
What is Amwell best used for?
Amwell is most often used for patient care, medical records, practice management, telehealth. Of those, patient care and medical records are not what Annalise.ai is typically brought in for.
What can Amwell do that Annalise.ai cannot?
Amwell covers Video Consultations, Phone Consultations, Mental Health Services, Prescription Services. Annalise.ai covers Annalise Enterprise CXR, Annalise Enterprise CTB, Triage and notification, Worklist reprioritisation.

Answered from the vendors’ own pages

Annalise.ai: How many findings are FDA cleared?

Around ten across chest X-ray and head CT, for triage and notification only. The model reports far more findings than that; the rest are not cleared in the United States.

Annalise.ai: Is the European position different?

Yes. CE marking under the medical device regulation covers a broader decision support indication than the United States triage and notification clearances, so the same software is a different regulatory product depending on where you deploy it.

Annalise.ai: Does it diagnose?

No. In the United States it is a triage and notification device: it flags studies for earlier review, and the radiologist makes the diagnosis.

Annalise.ai: Is Annalise.ai becoming Harrison.ai?

The critical care offering is now marketed under the Harrison.ai name. Ask the vendor to name the contracted product explicitly before signing a multi-year deal.

Share

Related pages

Other head to heads